[1]于超平,姚建晗,高 原,等.白细胞介素-6与骨质疏松相关研究进展[J].新乡医学院学报,2017,34(11):1040-1042.[doi:10.7683/xxyxyxb.2017.11.022]
点击复制

白细胞介素-6与骨质疏松相关研究进展
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
34
期数:
2017年11
页码:
1040-1042
栏目:
综述
出版日期:
2017-11-05

文章信息/Info

作者:
于超平1姚建晗1高 原2曹新生2
(1.空军军医大学学员一旅一营三连,陕西 西安 710032;2.空军军医大学航空航天医学系航空航天生物动力学教研室,陕西 西安 710032)
关键词:
白细胞介素-6骨质疏松雌激素溶骨作用
分类号:
R681
DOI:
10.7683/xxyxyxb.2017.11.022
文献标志码:
A
摘要:
白细胞介素-6(IL-6)是一种与临床骨丢失关系密切的细胞因子。本文就近年来国内外关于IL-6与骨质疏松的相关研究进行综述,归纳总结了IL-6的基本生物学特性、IL-6调控骨质疏松的机制、IL-6相关药物在骨质疏松治疗上的临床应用等,并就IL-6的研究及临床应用前景进行了展望。

参考文献/References:

[1] 尚云,杨卫红,任芳,等.缺氧缺血性脑病新生儿血清白细胞介素-6和S-100 β 蛋白水平变化及临床意义[J].新乡医学院学报,2017,34(5):378-380.
[2] 甘拓域,王成龚,晓辉康,等.白细胞介素-6基因RSl800796位点多态性与肠道病毒71型感染的相关性[J].中华实用儿科临床杂志,2017,32(6):457-460.
[3] JOHNSON R W,MCGREGOR N E,BRENNAN H J,et al.Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone[J].Bone,2015,81:343-351.
[4] WRIGHT H L,MCCARTHY H S,MIDDLETON J,et al.RANK,RANKL and osteoprotegerin in bone biology and disease[J].Curr Rev Musculoskelet Med,2009,2(1):56-64.
[5] KIM M H,JUNG K,NAM K H,et al.Salvia plebeia R.Br.inhibits signal transduction of IL-6 and prevents ovariectomy-induced bone loss by suppressing osteoclastogenesis[J].Arch Pharm Res,2016,39(12):1671-1681.
[6] SCHEIDT-NAVE C,BISMAR H,LEIDIG-BRUCKNER G,et al.Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause[J].J Clin Endocrinol Metab,2001,86(5):2032-2042.
[7] 方秀统,李洋,于方,等.白细胞介素-6在老年骨质疏松发病机制中的作用[J].中国老年学杂志,2014,34(24):6917-6919.
[8] 张玉领,陈培,刘家秀,等.中国汉族人群IL-6与骨质疏松相关性的Meta分析[J].中国老年学杂志,2014,34(6):1495-1496.
[9] 邱奕雁,朱峰,蓝涛,等.IL-6,IL-1β及TNF-α与大鼠骨质疏松形成的关系[J].现代生物医学进展,2016,16(18):3448-3451.
[10] POLI V,BALENA R,FATTORI E,et al.Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion[J].EMBO J,1994,13(5):1189-1196.
[11] DE BENEDETTI F,RUCCI N,DEL FATTORE A,et al.Impaired skeletal development in interleukin-6-transgenic mice:a model for the impact of chronic inflammation on the growing skeletal system[J].Arthritis Rheum,2006,54(11):3551-3563.
[12] WANG C Y,TIAN L,ZHANG K,et al.Interleukin-6 gene knockout antagonizes high-fat-induced trabecular bone loss[J].J Mol Endocrinol,2016,57(3):161-170.
[13] PERUZZI B,CAPPARIELLO A,DEL FATTORE A,et al.c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling[J].Nat Commun,2012,3:630.
[14] KANESHIRO S,EBINA K,SHI K,et al.IL-6 negatively regulates osteoblast differentiation through the SHP2/MEK2 and SHP2/Akt2 pathways in vitro[J].J Bone Miner Metab,2014,32(4):378-392.
[15] YOSHITAKE F,ITOH S,NARITA H,et al.Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-kappa B signaling pathways[J].J Biol Chem,2008,283(17):11535-11540.
[16] AXMANN R,BHM C,KRNKE G,et al.Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo[J].Arthritis Rheum,2009,60(9):2747-2756.
[17] KIM S,YAMAZAKI M,SHEVDE N K,et al.Transcriptional control of receptor activator of nuclear factor-κB ligand by the protein kinase A activator forskolin and the transmembrane glycoprotein 130-activating cytokine,oncostatin M,is exerted through multiple distal enhancers[J].Mol Endocrinol,2007,21(1):197-214.
[18] CHEUNG W Y,SIMMONS C A,YOU L.Osteocyte apoptosis regulates osteoclast precursor adhesion via osteocytic IL-6 secretion and endothelial ICAM-1 expression[J].Bone,2012,50(1):104-110.
[19] CZERNY B,KAMINSKI A,KURZAWSKI M,et al.The association of IL-1b,IL-2,and IL-6 gene polymorphisms with bone mineral density and osteoporosis in postmenopausal women[J].Eur J Obstet Gynecol Reprod Biol,2010,149(1):82-85.
[20] NI Y,LI H,ZHANG Y,et al.Association of IL-6 G-174C polymorphism with bone mineral density[J].J Bone Miner Metab,2014,32(2):167-173.
[21] YAN L,HU R,TU S,et al.Meta-analysis of association between IL-6-634C/G polymorphism and osteoporosis[J].Genet Mol Res,2015,14(4):19225-19232.
[22] 盛斌,张宏其,黄佳,等.成骨细胞中雌激素受体β介导雌激素对IL-6和TGF-β的调控作用[J].中国矫形外科杂志,2015,23(9):832-839.
[23] QUAEDACKERS M E,VAN DEN BRINK C E,WISSINK S,et al.4-hydroxy-tamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha,and not through ER beta[J].Endocrinology,2001,142(3):1156-1166.
[24] 邢俊平,吴齐飞,邱曙东.雄激素与骨质疏松[J].中国男科学杂志,2007,21(8):64-70.
[25] KUNG A W.Androgen and bone mass in men[J].Asian J Androl,2003,5(2):148-154.
[26] 罗玉明,郑维篷,魏合伟.骨关节炎与细胞因子TNF-α、IL-6 关系的研究进展[J].现代诊断与治疗,2013,24(2):326-327.
[27] LAZZERINI P E,CAPPERUCCI C,SPREAFICO A,et al.Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells[J].Joint Bone Spine,2013,80 (2):195-200.
[28] 杨超,曾艳平,杨桐,等.阿司匹林抑制去势大鼠IL-1,IL-6,TNF-α和M-CSF的表达及其防治绝经后骨质疏松作用的研究[J].中国药业,2015,24(21):15-17.
[29] 刘丹,王敏,陈群,等.硝酸镓治疗骨质疏松大鼠血清IL-6、骨钙素水平及骨结构的研究[J].中国地方病防治杂志,2013,28(4):280-281.
[30] ERIKSEN E F,DEZ-PREZ A,BOONEN S,et al.Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis:asystematic review[J].Bone,2014,58:126-135.
[31] ANDERSSON A,BERNARDI A I,STUBELIUS A,et al.Selective oestrogen receptor modulators lasofoxifene and bazedoxifene inhibit joint inflammation and osteoporosis in ovariectomised mice with collagen-induced arthritis[J].Rheumatology (Oxford),2016,55(3):553-563.
[32] MIRKIN S,KOMM B S,PAN K,et al.Effects of bazedoxifene /conjugated estrogens on endometrial safety and bone in postmenopausal women[J].Climacteric,2013,16(3):338-346.
[33] AMORY J K,WATTS N B,EASLEY K A,et al.Exogenous testosterone or testosterone with finasteride increases bone mineral desity in older men with low serum testosterone[J].J Clin Endocrinol Metab,2004,89(2):503-510.
[34] 柴仪,李倩,刘法敬,等.补肾活血方对骨质疏松大鼠血清细胞因子水平的影响[J].临床合理用药,2015,8(8A):60-61.
[35] 朱贵忱,刘明雨,宋雪花,等.淫羊藿联合钙尔奇D对老年骨质疏松症患者IL-6和TNF-α的影响[J].河北医药,2014,36(3):325-326.
[36] 张晓君,聂晶,熊静芳,等.补肾活血中药联合补钙剂治疗老年骨质疏松症100例临床研究[J].中医杂志,2013,54(18):1562-1565.
[37] 白洁,赵红斌,王朝旭,等.脉冲电磁场对去势大鼠腰椎细胞因子IL-6、TNF-α和骨密度的影响[J].西北国防医学杂志,2011,32(2):115-117.

相似文献/References:

[1]张永喜 高 倩 刘玉府 杨 坤 孔小娟 张静涵 李万里 田玉慧 桂立辉.碳酸钙和生物钙对大鼠废用性骨质疏松症的作用[J].新乡医学院学报,1999,16(04):306.
[2]李亚伟,徐剀.两种补钙方式预防孕妇骨质疏松疗效比较[J].新乡医学院学报,2003,20(02):135.
[3]李亚伟,徐 剀.两种补钙方式预防孕妇骨质疏松疗效比较[J].新乡医学院学报,2003,20(02):135.
[4]付克广,肖江喜,韩东明。.脊柱外伤及原发性骨质疏松椎体压缩的MRI诊断[J].新乡医学院学报,2003,20(03):172.
[5]田玉慧,娄静,李万里,等.麦胚提取物对去卵巢大鼠骨密度和矿物质的作用[J].新乡医学院学报,2003,20(03):153.
[6]付克广,肖江喜,韩东明.脊柱外伤及原发性骨质疏松椎体压缩的MRI诊断[J].新乡医学院学报,2003,20(03):172.
[7]田玉慧,娄 静,李万里,等.麦胚提取物对去卵巢大鼠骨密度和矿物质的作用[J].新乡医学院学报,2003,20(03):153.
[8]裴凌鹏,崔箭,高兆兰,等.玉米黄质对D-半乳糖致衰老大鼠骨质的影响[J].新乡医学院学报,2008,25(05):436.
[9]王佳贺,任开明,姜洪芳,等.肠致病性大肠杆菌毒力因子EspF对肿瘤坏死因子-α、白细胞介素-6 和白细胞介素-8的影响[J].新乡医学院学报,2011,28(03):265.
 WANG Jia-he,REN Kai-ming,JIANG Hong-fang,et al.Effect of virulence factor EspF from enteropathic E.coli on tumor necrosis factor-α,interleukin-6[J].Journal of Xinxiang Medical University,2011,28(11):265.
[10]刘 菊,梅群超,谢先龙,等.温阳补肾方对去卵巢大鼠骨密度及骨标志物的影响[J].新乡医学院学报,2014,31(06):426.[doi:10.7683/xxyxyxb.2014.06.006]

更新日期/Last Update: 2017-11-05